GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Cyclically Adjusted FCF per Share

Polynovo (Polynovo) Cyclically Adjusted FCF per Share : $-0.01 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Polynovo Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Polynovo's adjusted free cash flow per share data for the fiscal year that ended in Jun. 2023 was $-0.008. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.01 for the trailing ten years ended in Jun. 2023.

During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Polynovo was 41.50% per year. The lowest was 12.60% per year. And the median was 26.55% per year.

As of today (2024-04-28), Polynovo's current stock price is $ 1.35. Polynovo's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jun. 2023 was $-0.01. Polynovo's Cyclically Adjusted Price-to-FCF of today is .


Polynovo Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Polynovo's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Cyclically Adjusted FCF per Share Chart

Polynovo Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.01

Polynovo Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - -0.01 -

Competitive Comparison of Polynovo's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Polynovo's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Polynovo's Cyclically Adjusted Price-to-FCF falls into.



Polynovo Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Polynovo's adjusted Free Cash Flow per Share data for the fiscal year that ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.008/124.1700*124.1700
=-0.008

Current CPI (Jun. 2023) = 124.1700.

Polynovo Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.006 98.352 -0.008
201506 -0.005 99.838 -0.006
201606 -0.006 100.859 -0.007
201706 -0.008 102.809 -0.010
201806 -0.008 104.945 -0.009
201906 -0.010 106.617 -0.012
202006 -0.010 106.246 -0.012
202106 -0.004 110.332 -0.005
202206 -0.003 117.112 -0.003
202306 -0.008 124.170 -0.008

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Polynovo  (OTCPK:CALZF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Polynovo Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Polynovo's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo (Polynovo) Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (Polynovo) Headlines

From GuruFocus

Half Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2020 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Investor Update Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024